By Laura Lutz
Washington, Feb. 15 - Devgen NV raised €31,245,952 from a private placement of shares.
The company sold 1,505,829 shares to institutional investors at €20.75 per share.
The company said that existing shareholders also sold 2,258,443 shares to institutional investors at the same price.
KBC Securities acted as lead manager, assisted by Petercam Group and Kempen & Co.
Based in Ghent, Belgium, Devgen is a biotechnology company focused on agriculture and treatments for metabolic diseases and inflammation.
| Issuer: | Devgen NV
|
| Issue: | Shares
|
| Amount: | €31,245,952
|
| Shares: | 1,505,829
|
| Price: | €20.75
|
| Warrants: | No
|
| Managers: | KBC Securities (lead), Petercam Group, Kempen & Co.
|
| Settlement date: | Feb. 15
|
| Stock symbol: | Brussels: DEVG
|
| Stock price: | €22.25 at close Feb. 15
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
